Factbox – Latest on the worldwide spread of the coronavirus – Metro US

Factbox – Latest on the worldwide spread of the coronavirus

FILE PHOTO: The retail store Primark in Birmingham, Britain reopens
FILE PHOTO: The retail store Primark in Birmingham, Britain reopens its doors after a third lockdown imposed in early January due to the ongoing coronavirus disease (COVID-19) pandemic

(Reuters) – Pfizer Inc and BioNTech once again requested the U.S. Food and Drug Administration on Tuesday to authorize booster doses of their COVID-19 vaccine for all adults.


* Eikon users, see COVID-19: MacroVitals https://apac1.apps.cp.thomsonreuters.com/cms/?navid=1592404098 for a case tracker and summary of news


* The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in the coming days, two EU sources told Reuters, in its first approvals of such therapies.

* Health workers in England will have to be vaccinated against COVID-19 by April 1, Health Minister Sajid Javid said.

* France registered 12,476 new confirmed COVID-19 infections, the highest since Sept. 8, health ministry data showed.

* Russia said last week’s nationwide workplace shutdown had helped turn the tide of surging COVID-19 cases, even as officials on Tuesday reported the largest one-day death toll of the pandemic so far.

* Latvia, one of the least vaccinated countries in the European Union, is facing its most severe outbreak of COVID-19 yet.


* The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck & Co Inc and partner Ridgeback Biotherapeutics, the companies said.

* Canada authorized the use of Pfizer/BioNTech’s, COVID-19 vaccine as a booster shot for people 18 years of age and older.


* AstraZeneca’s antibody cocktail against COVID-19 received its first nod for registration in Australia, the country’s medical regulatory body said.


* Israeli health officials will decide behind closed doors on whether to allow child COVID-19 vaccinations.


* Moderna Inc applied for European authorization of its vaccine in children aged 6-11 years, weeks after it delayed a similar filing with U.S. regulators.

* Inovio Pharmaceuticals Inc said the U.S. Food and Drug Administration had lifted a partial clinical hold on late-stage trial of its COVID-19 vaccine within the country.

* A Bangladeshi drugmaker will soon begin selling the world’s first generic version of Merck’s COVID-19 pill, molnupiravir, which has been touted as a potential game-changer in the fight against the pandemic.


* World stock indexes retreated from record highs as a solid rise in producer prices last month deepened concerns over inflation, while U.S. Treasury yields edged lower. [MKTS/GLOB]

* U.S. consumers are spending more and ramping up credit card balances, reversing a shift during the COVID-19 crisis, when they scaled back spending and substantially paid down debt, a Federal Reserve Bank of New York report showed.

(Compiled by Anita Kobylinska, Federico Maccioni and Vinay Dwivedi; Editing by Ed Osmond, Matthew Lewis and Sriraj Kalluvila)

More from our Sister Sites